Page last updated: 2024-11-05

iodoantipyrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Iodoantipyrine is a synthetic derivative of antipyrine, a pyrazolone compound. It was initially synthesized in the late 19th century and was historically used as an analgesic and antipyretic agent. However, its use has declined due to the development of safer and more effective alternatives. Iodoantipyrine is characterized by the presence of an iodine atom on its molecular structure, which contributes to its pharmacological properties. Research on iodoantipyrine has focused on its potential applications in analytical chemistry, specifically in the detection and determination of various analytes, such as proteins and enzymes, through its ability to form colored complexes. Iodoantipyrine is also studied for its potential use as a reagent in spectrophotometric methods for the analysis of certain substances. Further research is needed to explore its full potential and safety profile for specific applications.'

Cross-References

ID SourceID
PubMed CID8522
CHEMBL ID24132
SCHEMBL ID1148899
MeSH IDM0051718

Synonyms (49)

Synonym
129-81-7
AC-5017
iodopyrine
einecs 204-966-6
jodopyrine
iodoantipyrine
3h-pyrazol-3-one, 1,2-dihydro-4-iodo-1,5-dimethyl-2-phenyl-
jodantipyrine
4-iodoantipyrine
1,2-dihydro-4-iodo-1,5-dimethyl-2-phenyl-2h-pyrazol-3-one
arthripur
1,2-dihydro-4-iodo-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one
iodophenazone
antipyrine iodide
4-iodo-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one
NCGC00159397-02
antipyrine, 4-iodo-
CHEMBL24132
4-iodo-1,5-dimethyl-2-phenylpyrazol-3-one
NCGC00159397-03
dtxsid7046047 ,
cas-129-81-7
dtxcid5026047
tox21_111636
AKOS005207004
4-iod-2,3-dimethyl-1-phenyl-3-pyrazolin-5-on
1,2-dihydro-4-iod-1,5-dimethyl-2-phenyl-3h-pyrazol-3-on
unii-v30v6h1qx4
1,2-dihydro-4-iod-1,5-dimethyl-2-phenyl-3h-pyrazol-3-on [iupac]
v30v6h1qx4 ,
FT-0618780
1,5-dimethyl-4-iodo-2-phenyl-1,2-dihydro-pyrazol-3-one
iodophenazone [who-dd]
tox21_111636_1
SCHEMBL1148899
ZZOBLCHCPLOXCE-UHFFFAOYSA-N
1-phenyl-2,3-dimethyltetrahydropyrazole hydroiodide
3h-pyrazol-3-one,1,2-dihydro-4-iodo-1,5-dimethyl-2-phenyl-
mfcd00040720
sr-01000945033
SR-01000945033-1
4-iodo-1,5-dimethyl-2-phenyl-1,2-dihydro-3h-pyrazol-3-one
Q4205877
E75849
4-iodo-1,5-dimethyl-2-phenyl-1h-pyrazol-3(2h)-one
AN-584/43522517
BS-52922
STL577304
CS-0063717

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In LD50 parameters it was found to be related to moderately toxic drugs."( [A preclinical trial of iodoantipyrine safety].
Akhmedzhanov, RR; Bashirova, LV; Burchenkova, FI; Eremina, AA; Kadychagova, NG; Livshits, NS; Novozheeva, TP; Potapova, GV; Saratikov, AS,
)
0.44

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" Our results demonstrate that the HSN tumour vasculature is selectively responsive to IRL 1620 at doses > 1 nmol kg(-1) compared with the majority of normal tissues with the exception of the small intestine, and that only the tumour response is highly sensitive to BQ-788 antagonism, under the experimental dosing regime investigated."( Modification of blood flow in the HSN tumour and normal tissues of the rat by the endothelin ET(B) receptor agonist, IRL 1620.
Bell, KM; Chaplin, DJ; Poole, BA; Prise, VE; Tozer, GM, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency43.64860.002541.796015,848.9004AID1347398
TDP1 proteinHomo sapiens (human)Potency33.49830.000811.382244.6684AID686978; AID686979
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency14.12540.01237.983543.2770AID1346984
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (80)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID173174Compound was evaluated for the measurement of Cerebral blood flow in medial geniculate body of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173192Compound was evaluated for the measurement of Cerebral blood flow in thalamus of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173190Compound was evaluated for the measurement of Cerebral blood flow in superior coliculus of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173022Compound was evaluated for the measurement of Cerebral blood flow in cingulate cortex of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173014Compound was evaluated for the measurement of Cerebral blood flow in amygdala of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173175Compound was evaluated for the measurement of Cerebral blood flow in nucleus accumbens of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173181Compound was evaluated for the measurement of Cerebral blood flow in piriform cortex of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173028Compound was evaluated for the measurement of Cerebral blood flow in habenula of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173188Compound was evaluated for the measurement of Cerebral blood flow in substantia nigra of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173179Compound was evaluated for the measurement of Cerebral blood flow in parietal cortex of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173016Compound was evaluated for the measurement of Cerebral blood flow in auditory cortex of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173025Compound was evaluated for the measurement of Cerebral blood flow in frontal cortex of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173030Compound was evaluated for the measurement of Cerebral blood flow in hippocampus cortex of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173184Compound was evaluated for the measurement of Cerebral blood flow in sensorimotor cortex of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173024Compound was evaluated for the measurement of Cerebral blood flow in frontal cortex of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173178Compound was evaluated for the measurement of Cerebral blood flow in nucleus ruber of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173182Compound was evaluated for the measurement of Cerebral blood flow in piriform cortex of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173183Compound was evaluated for the measurement of Cerebral blood flow in sensorimotor cortex of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173035Compound was evaluated for the measurement of Cerebral blood flow in inferior coliculus of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173017Compound was evaluated for the measurement of Cerebral blood flow in auditory cortex of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173037Compound was evaluated for the measurement of Cerebral blood flow in lateral geniculate body of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173033Compound was evaluated for the measurement of Cerebral blood flow in hypothalamus of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173023Compound was evaluated for the measurement of Cerebral blood flow in cingulate cortex of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173018Compound was evaluated for the measurement of Cerebral blood flow in caudoputamen of Rats ((hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173034Compound was evaluated for the measurement of Cerebral blood flow in inferior coliculus of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173194Compound was evaluated for the measurement of Cerebral blood flow in visual cortex of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173193Compound was evaluated for the measurement of Cerebral blood flow in visual cortex of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173026Compound was evaluated for the measurement of Cerebral blood flow in globus pallidus of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173032Compound was evaluated for the measurement of Cerebral blood flow in hypothalamus of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173180Compound was evaluated for the measurement of Cerebral blood flow in parietal cortex of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173029Compound was evaluated for the measurement of Cerebral blood flow in habenula of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173176Compound was evaluated for the measurement of Cerebral blood flow in nucleus accumbens of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173021Compound was evaluated for the measurement of Cerebral blood flow in cerebellum of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173173Compound was evaluated for the measurement of Cerebral blood flow in medial geniculate body of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173187Compound was evaluated for the measurement of Cerebral blood flow in substantia nigra of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173031Compound was evaluated for the measurement of Cerebral blood flow in hippocampus cortex of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173186Compound was evaluated for the measurement of Cerebral blood flow in septal nucleus of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173020Compound was evaluated for the measurement of Cerebral blood flow in cerebellum of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173019Compound was evaluated for the measurement of Cerebral blood flow in caudoputamen of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173177Compound was evaluated for the measurement of Cerebral blood flow in nucleus ruber of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173191Compound was evaluated for the measurement of Cerebral blood flow in thalamus of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173027Compound was evaluated for the measurement of Cerebral blood flow in globus pallidus of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173189Compound was evaluated for the measurement of Cerebral blood flow in superior coliculus of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173036Compound was evaluated for the measurement of Cerebral blood flow in lateral geniculate body of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173015Compound was evaluated for the measurement of Cerebral blood flow in amygdala of Rats (normocapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
AID173185Compound was evaluated for the measurement of Cerebral blood flow in septal nucleus of Rats (hypercapnia)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
11C-labeled 4-isopropylantipyrine: preparation and biological evaluation as a blood flow tracer in positron emission tomography (PET).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (317)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990117 (36.91)18.7374
1990's120 (37.85)18.2507
2000's53 (16.72)29.6817
2010's21 (6.62)24.3611
2020's6 (1.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.62 (24.57)
Research Supply Index5.82 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (13.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.19%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other332 (98.81%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]